Yüklüyor......
Targeting the Vulnerability of RB Tumor Suppressor Loss in Triple-Negative Breast Cancer
Approximately 30% of triple-negative breast cancers (TNBCs) exhibit functional loss of the RB tumor suppressor, suggesting a target for precision intervention. Here, we use drug screens to identify agents specifically antagonized by the retinoblastoma tumor suppressor (RB) using CDK4/6 inhibitors. A...
Kaydedildi:
| Yayımlandı: | Cell Rep |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5967622/ https://ncbi.nlm.nih.gov/pubmed/29386107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2018.01.022 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|